Which abstract presented during the plenary session of the ASCO Annual Meeting do you think will have the most impact on clinical practice? (poll 9442318)

Which abstract presented during the plenary session of the ASCO Annual Meeting do you think will have the most impact on clinical practice?

•MA.17R: Randomized trial of extending adjuvant letrozole for 5 years in postmenopausal women with early-stage breast cancer.

•Phase 3 trial of short-course radiotherapy with or without temozolomide in elderly patients with glioblastoma.

•Phase 3 trial of autologous stem cell transplant using peripheral blood stem cells as consolidation therapy for high-risk neuroblastoma.

•CASTOR: Study of the addition of daratumumab to bortezomib and dexamethasone for relapsed/refractory multiple myeloma.

Submit View Results

See this poll on: https://poll.fm/9442318/embed